Novartis receives EC approval for Cosentyx in hidradenitis suppurativa
PM Live
by
4h ago
There are around 200,000 people in Europe living with moderate to severe stages of HS ..read more
Visit website
Pfizer’s RSV vaccine approved by FDA for older adults
PM Live
by
4h ago
RSV infections in older adults account for up to 160,000 hospitalisations each year in the US ..read more
Visit website
Engaging with patients will create more effective patient pathways
PM Live
by
4h ago
By Su Smith ..read more
Visit website
Sanofi's frexalimab shows promise in relapsing forms of MS
PM Live
by
1d ago
The neurological disease affects approximately 2.8 million people worldwide ..read more
Visit website
Amgen reports positive results for Otezla in psoriatic arthritis
PM Live
by
1d ago
The inflammatory condition is estimated to affect nearly 38 million people worldwide ..read more
Visit website
Listening to patients when they have something to say, not just when we want an answer
PM Live
by
1d ago
By Harry Yeates ..read more
Visit website
UK life sciences sector to receive £650m in government funding
PM Live
by
2d ago
The package includes £121m to speed up clinical trials and improve access to real-time data ..read more
Visit website
EMA recommends revoking marketing authorisation for Novartis’ sickle cell disease drug
PM Live
by
2d ago
The EU regulator concluded that the benefits of Adakveo did not outweigh its risks ..read more
Visit website
COVID-19: Pfizer’s Paxlovid approved by FDA and Gilead’s Veklury recommended by CHMP
PM Live
by
6d ago
Pfizer’s oral antiviral has been available in the US since 2021 under the accelerated approval pathway ..read more
Visit website
Gene therapy, gene editing and perspectives on future use in Parkinson’s disease
PM Live
by
6d ago
By Alice Waterhouse ..read more
Visit website

Follow PM Live on Feedspot

Continue with Google
Continue with Apple
OR